SMTL ID : 8qjs.3 (3 other biounits)

VHL/Elongin B/Elongin C complex with compound 155

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.19 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x VL6: (2S,4R)-1-[(2R)-2-[3-[2-(2-methoxyethoxy)ethoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

VL6.1: 15 residues within 4Å: Chain C: N.16, R.18, F.25, P.35, W.37, F.40, Y.47, P.48, R.56, I.58, H.59, S.60, Y.61, H.64, W.66 15 PLIP interactions: 15 interactions with chain C Hydrophobic interactions: C:W.37, C:W.37, C:P.48, C:I.58, C:H.59, C:W.66 Hydrogen bonds: C:R.18, C:Y.47, C:R.56, C:H.59, C:Y.61, C:Y.61, C:H.64 pi-Stacking: C:Y.47, C:Y.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Berlin, M. et al., PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models. J.Med.Chem. (2024)

Release Date

2024-01-17

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

C
I

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence